Cure8 research brief
The review connects animal-model discoveries (IL-23/IL-17 and TNF pathways, gut–joint interactions) to therapies and research priorities relevant to people with SpA and IBD-associated arthritis.
Researchers studying SpA/IBD pathogenesis, translational scientists developing models or therapies, and clinicians interested in the mechanistic basis of existing biologic treatments.
The paper is a review of experimental (mostly rodent) SpA models and does not present new clinical trial data.
It describes strengths and limits of different models, how they have supported the role of IL-23/IL-17 and TNF signaling, and how models have informed ideas about enthesitis, axial disease, and extra‑articular features such as uveitis, psoriasis, and gut involvement.
The authors discuss approaches intended to improve translational relevance, including humanized mouse models, microbiome engineering, and multi-omic integration. These are presented as strategies to narrow the gap between animal findings and human disease, not as established clinical tools.
The article is a review of experimental animal models (rodent-focused) and the structured content is grounded in the source abstract rather than primary new clinical data.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of competing interest The authors declare that they have no competing interests or financial conflicts related to the content of this article.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Researchers and clinicians are exploring how fucose metabolism affects gut barrier function, immunity, and microbiota — processes central to IBD and colorectal cancer. If validated, fucosylation biomarkers or treatments...
Intestinal fibrosis causes strictures that often need surgery and has few effective medical treatments; linking the microbiome to fibrogenesis suggests new prevention or treatment strategies that could reduce surgery...
Intestinal fibrosis and strictures remain a major cause of surgery and obstruction in Crohn’s disease, and current anti-inflammatory drugs don’t reliably prevent fibrosis. If microbial choline degradation promotes...
